SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
BioCardia, Inc.
@BCDA_InsiderForm 4 Filing: GILLIS EDWARD M Acquires (Grant) $47,425.2 of $BCDA
STOCK AWARD / GRANT
⚡ MATERIALITY: 3/10
corporate issuer
BioCardia, Inc.
Ticker: $BCDA
Transaction Value
$47,425.2
Price/Share: $1.20
transaction date
2026-06-29
Shares: 39,521
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GILLIS EDWARD M, holds the title of Senior Vice President, Devices at BioCardia, Inc..
On 2026-06-29, the insider transacted 39,521 shares.The shares were transacted at a weighted average price of $1.20 per share, resulting in a total market-relevant value of $47,425.2.
Executive Summary Summary
GILLIS EDWARD M (Senior Vice President, Devices) was granted $47K of $BCDA
Post-Transaction Position: 71,395 shares
SEC Accession No: 0001437749-26-022363 (CIK: 1241359)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.